BioSpace News Archive

Business

Exscientia to Report Full Year 2022 Financial Results on March 23, 2023

Exscientia plc (Nasdaq: EXAI) will report financial results for the fourth quarter and full year ended December 31, 2022 on Thursday, March 23, 2023 before the open of U.S. markets.

March 16, 2023
·
1 min read
Business

LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

LENSAR, Inc. today announced financial results for the quarter and full year ended December 31, 2022 and provided an update on key operational initiatives.

March 16, 2023
·
14 min read
BioCapital

GlycoMimetics to Report Fourth Quarter and 2022 Full Year Financial Results on March 29, 2023

GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report fourth quarter and 2022 full year financial results on Wednesday, March 29, 2023, at 8:30 a.m. ET.

March 16, 2023
·
1 min read
Business

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook

Apyx Medical Corporation today reported financial results for its fourth quarter and full year ended December 31, 2022, and introduced financial expectations for the full year ending December 31, 2023.

March 16, 2023
·
17 min read
Business

IMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational Results

IMV Inc. today announced alongside the release of its fourth quarter and annual results that it has engaged Stonegate Healthcare Partners, L.L.C (“Stonegate”) to explore strategic alternatives following a review of its business.

March 16, 2023
·
14 min read
Business

MediWound Reports Fourth Quarter and Full Year 2022 Financial Results and Company Update

MediWound Ltd. (NASDAQ: MDWD), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced financial results for the fourth quarter and the year ended December 31, 2022 and provided a corporate update.

March 16, 2023
·
18 min read
Bulletin from the extraordinary general meeting in Immunovia AB

On 16th March 2023, an extraordinary general meeting was held in Immunovia AB, 556730-4299 at The Spark, Scheeletorget 1, Medicon Village, in Lund.

March 16, 2023
·
3 min read
Business

Affimed to Report Full Year 2022 Financial Results & Corporate Update on March 23, 2023

Affimed N.V., a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced that it will release full year 2022 results and corporate update on Thursday, March 23, 2023.

March 16, 2023
·
1 min read
Genetown

World-Renowned Cardiologists and Cardiac Surgeons to Feature Innovative Heart Failure Therapies at Technology and Heart Failure Therapeutics, March 20-22, 2023

Innovative therapeutic approaches for left ventricular restoration for patients with Heart Failure with Reduced Ejection Fraction (HFrEF).

March 16, 2023
·
2 min read
Business

Nuvalent Highlights Pipeline and Business Progress and Reports Fourth Quarter and Full Year 2022 Financial Results

Nuvalent, Inc., a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, highlighted pipeline and business progress and fourth quarter and full year 2022 financial results.

March 16, 2023
·
10 min read